APA (7th ed.) Citation

Ichikawa, W., Uetake, H., Shirota, Y., Yamada, H., Takahashi, T., Nihei, Z., . . . Hirayama, R. (2003). Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer. British Journal of Cancer, 89(8), 1486. https://doi.org/10.1038/sj.bjc.6601335

Chicago Style (17th ed.) Citation

Ichikawa, W., H. Uetake, Y. Shirota, H. Yamada, T. Takahashi, Z. Nihei, K. Sugihara, Y. Sasaki, and R. Hirayama. "Both Gene Expression for Orotate Phosphoribosyltransferase and Its Ratio to Dihydropyrimidine Dehydrogenase Influence Outcome Following Fluoropyrimidine-based Chemotherapy for Metastatic Colorectal Cancer." British Journal of Cancer 89, no. 8 (2003): 1486. https://doi.org/10.1038/sj.bjc.6601335.

MLA (9th ed.) Citation

Ichikawa, W., et al. "Both Gene Expression for Orotate Phosphoribosyltransferase and Its Ratio to Dihydropyrimidine Dehydrogenase Influence Outcome Following Fluoropyrimidine-based Chemotherapy for Metastatic Colorectal Cancer." British Journal of Cancer, vol. 89, no. 8, 2003, p. 1486, https://doi.org/10.1038/sj.bjc.6601335.